Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
BICILLIN L-A-benzathine benzylpenicillin tetrahydrate 600,000 units/1.17 mL suspension for injection syringe with needle, Pfizer Australia Pty Ltd, CON-1060
Product name
BICILLIN L-A-benzathine benzylpenicillin tetrahydrate 600,000 units/1.17 mL suspension for injection syringe with needle
Sponsor name
Pfizer Australia Pty Ltd
Batches
FC3933
Consent start
Consent no.
CON-1060
Standard
United States Pharmacopeia-National Formulary (USP-NF) monograph for Lecithin of United States Pharmacopoeia
Non-compliance with standard
The products do not meet the specification for 'Assay: Content of Phospholipids'
of NLT 70.0% for phosphatidylcholine
Therapeutic product type
Prescription medicines